DARSHANEY SANKHAR: Open Payments
NPI 1043688112 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 41 payments from 7 companies in 2025. Trend: 2023 $1,085 · 2024 $1,256 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $452 |
| PFIZER INC. | 8 | $135 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Amgen Inc. | 3 | $43 |
| CVRx, Inc. | 2 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: LEQVIO, ELIQUIS, WAINUA, JARDIANCE, REPATHA, VYNDAQEL, Barostim Neo System, CAMZYOS.
Industry payments across NY — which companies pay providers there.
